Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03598829 · ClinicalTrials.gov registry record
A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 219
- Enrollment target
NCT03598829: Completed study, sponsored by Mayo Clinic.
NCT03598829 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 219 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03598829 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 219 participants
- Enrollment target
Study Summary
This research is being done to see if the amount of an enzyme in blood (called serum mast cell tryptase) changes before and after surgery. The investigators would like to see if these amounts are related to knee stiffness and pain in subjects that undergo a total knee replacement.
Interventions
- DIAGNOSTIC_TEST Tryptase, Serum test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2023-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03598829
The ClinicalTrials.gov registry entry for NCT03598829 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tryptase, Serum test is the first listed.
NCT03598829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03598829 about?
NCT03598829 is a clinical study titled "A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients". This research is being done to see if the amount of an enzyme in blood (called serum mast cell tryptase) changes before and after surgery. The investigators would like to see if these amounts are related to knee stiffness and pain in subjects that undergo a total knee replacement.
What is the current status of trial NCT03598829?
This trial is currently completed. The enrollment target is 219 participants. The study started on 2018-07-01. Estimated completion is 2023-11-15.
What interventions are being tested in trial NCT03598829?
The interventions under investigation include: Tryptase, Serum test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03598829?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.